Keerthanaa B, Rashmi Appaji, Levin Thomas, Tejaswini Baral, Skanda N, Chaithra, Sonal Sekhar M, Kavitha Saravu, Krishna Undela, Mahadev Rao
PURPOSE: Isoniazid, a first-line antitubercular drug, is associated with nervous system adverse drug reactions such as seizures, peripheral neuropathy, and psychosis. This systematic review of case reports and case series aimed to characterize the demographic, social, and clinical factors associated with isoniazid-induced psychosis in patients with active tuberculosis (TB) and those who received isoniazid for latent TB infection (LTBI). METHODS: We comprehensively searched the Embase, PubMed, and Scopus databases to identify relevant studies published between the date of inception of the database and June 2024...
August 13, 2024: European Journal of Clinical Pharmacology